For instance, in medulloblastoma, the use of DNA methylation inhibitors (e.g., 5-aza-deoxycytidine) to restore miR-199b-5p expression can inhibit tumor stem cells by negatively regulating Hes1 (128). This evidence concerns the gene HES1 and medulloblastoma.